[Fully bioresorbable drug-eluting coronary scaffolds: A review]

Comite dĀ“Evaluation et de Diffusion des Innovations Technologiques (CEDIT)
Record ID 32015001191
Authors' objectives: Following the development of stents, then drug-eluting stents (DES), bioresorbable scaffolds are proposed as a third evolution in coronary angioplasty, aiming to reduce the incidence of restenosis and stent thrombosis and to restore vascular physiology. At least 16 such devices are currently under development, but published clinical data were available for only three of them in September 2014.
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
MeSH Terms
  • Coronary Artery Disease
  • Absorbable Implants
  • Drug-Eluting Stents
  • Percutaneous Coronary Intervention
Organisation Name: Cellule Innovation of the AP-HP
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.